Literature DB >> 23891695

Availability of the key metabolic substrates dictates the respiratory response of cancer cells to the mitochondrial uncoupling.

Alexander V Zhdanov1, Alicia H C Waters, Anna V Golubeva, Ruslan I Dmitriev, Dmitri B Papkovsky.   

Abstract

Active glycolysis and glutaminolysis provide bioenergetic stability of cancer cells in physiological conditions. Under hypoxia, metabolic and mitochondrial disorders, or pharmacological treatment, a deficit of key metabolic substrates may become life-threatening to cancer cells. We analysed the effects of mitochondrial uncoupling by FCCP on the respiration of cells fed by different combinations of Glc, Gal, Gln and Pyr. In cancer PC12 and HCT116 cells, a large increase in O2 consumption rate (OCR) upon uncoupling was only seen when Gln was combined with either Glc or Pyr. Inhibition of glutaminolysis with BPTES abolished this effect. Despite the key role of Gln, addition of FCCP inhibited respiration and induced apoptosis in cells supplied with Gln alone or Gal/Gln. For all substrate combinations, amplitude of respiratory responses to FCCP did not correlate with Akt, Erk and AMPK phosphorylation, cellular ATP, and resting OCR, mitochondrial Ca(2+) or membrane potential. However, we propose that proton motive force could modulate respiratory response to FCCP by regulating mitochondrial transport of Gln and Pyr, which decreases upon mitochondrial depolarisation. As a result, an increase in respiration upon uncoupling is abolished in cells, deprived of Gln or Pyr (Glc). Unlike PC12 or HCT116 cells, mouse embryonic fibroblasts were capable of generating pronounced response to FCCP when deprived of Gln, thus exhibiting lower dependence on glutaminolysis. Overall, the differential regulation of the respiratory response to FCCP by metabolic environment suggests that mitochondrial uncoupling has a potential for substrate-specific inhibition of cell function, and can be explored for selective cancer treatment.
© 2013.

Entities:  

Keywords:  AMP-activated protein kinase; AMPK; Akt; BPTES; Cancer cell; D-galactose; D-glucose; DMEM; DMSO; Dulbecco's Modified Eagle's medium; ECA; ETC; Erk; FBS; FCCP; GLS1; GLUT; GSH; Gal; Glc; Gln; Glu; Glutaminolysis; Glycolysis; HS; L-glutamine; MEFs; Metabolic substrate; Mitochondrial respiration; NGF; OCR; OxPhos; PMF; PMPI; Pi; Pyr; ROS; RPMI; Roswell Park Memorial Institute; TMRM; Uncoupling; WM; bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide; carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone; dimethyl sulphoxide; electron transport chain; extracellular acidification; fetal bovine serum; glucose transporter; glutamate; glutathione; horse serum; iO(2); inorganic phosphate; intracellular oxygen; kidney-type glutaminase; mitochondrial membrane potential; mitochondrial proton gradient; mitogen-activated protein kinase (MAPK); mouse embryonic fibroblasts; nerve growth factor; oxidative phosphorylation; oxygen consumption rate; plasma membrane potential; plasma membrane potential indicator; protein kinase B (PKB); proton motive force; pyruvate; reactive oxygen species; tetramethyl rhodamine methyl ester; working media; ΔpH; ΔΨm; ΔΨp; α-KG; α-ketoglutarate

Mesh:

Substances:

Year:  2013        PMID: 23891695     DOI: 10.1016/j.bbabio.2013.07.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  21 in total

1.  Fatty Acid Metabolism and Cancer.

Authors:  Zhenning Jin; Yang D Chai; Shen Hu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Substrate-dependent differential regulation of mitochondrial bioenergetics in the heart and kidney cortex and outer medulla.

Authors:  Namrata Tomar; Xiao Zhang; Sunil M Kandel; Shima Sadri; Chun Yang; Mingyu Liang; Said H Audi; Allen W Cowley; Ranjan K Dash
Journal:  Biochim Biophys Acta Bioenerg       Date:  2021-12-03       Impact factor: 3.991

3.  Imaging oxygen in neural cell and tissue models by means of anionic cell-permeable phosphorescent nanoparticles.

Authors:  Ruslan I Dmitriev; Sergey M Borisov; Alina V Kondrashina; Janelle M P Pakan; Ujval Anilkumar; Jochen H M Prehn; Alexander V Zhdanov; Kieran W McDermott; Ingo Klimant; Dmitri B Papkovsky
Journal:  Cell Mol Life Sci       Date:  2014-07-09       Impact factor: 9.261

4.  Energy restriction causes metaphase delay and chromosome mis-segregation in cancer cells.

Authors:  Aoxing Cheng; Ya Jiang; Ting Wang; Fazhi Yu; Iqra Ishrat; Dongming Zhang; Xiaoyang Ji; Minhua Chen; Weihua Xiao; Qing Li; Kaiguang Zhang; Gang Niu; Jue Shi; Yueyin Pan; Zhenye Yang; Jing Guo
Journal:  Cell Cycle       Date:  2021-05-28       Impact factor: 5.173

Review 5.  Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach.

Authors:  Lian Chen; Hengmin Cui
Journal:  Int J Mol Sci       Date:  2015-09-22       Impact factor: 5.923

6.  Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ß-lapachone.

Authors:  Gaurab Chakrabarti; Zachary R Moore; Xiuquan Luo; Mariya Ilcheva; Aktar Ali; Mahesh Padanad; Yunyun Zhou; Yang Xie; Sandeep Burma; Pier P Scaglioni; Lewis C Cantley; Ralph J DeBerardinis; Alec C Kimmelman; Costas A Lyssiotis; David A Boothman
Journal:  Cancer Metab       Date:  2015-10-12

7.  CtBP maintains cancer cell growth and metabolic homeostasis via regulating SIRT4.

Authors:  L Wang; H Zhou; Y Wang; G Cui; L-J Di
Journal:  Cell Death Dis       Date:  2015-01-29       Impact factor: 8.469

8.  The HMGB1 protein induces a metabolic type of tumour cell death by blocking aerobic respiration.

Authors:  Georg Gdynia; Sven W Sauer; Jürgen Kopitz; Dominik Fuchs; Katarina Duglova; Thorsten Ruppert; Matthias Miller; Jens Pahl; Adelheid Cerwenka; Markus Enders; Heimo Mairbäurl; Marcin M Kamiński; Roland Penzel; Christine Zhang; Jonathan C Fuller; Rebecca C Wade; Axel Benner; Jenny Chang-Claude; Hermann Brenner; Michael Hoffmeister; Hanswalter Zentgraf; Peter Schirmacher; Wilfried Roth
Journal:  Nat Commun       Date:  2016-03-07       Impact factor: 14.919

9.  Molecular link between glucose and glutamine consumption in cancer cells mediated by CtBP and SIRT4.

Authors:  Li Wang; Jing-Jing Li; Li-Yu Guo; Peipei Li; Zhiqiang Zhao; Haisheng Zhou; Li-Jun Di
Journal:  Oncogenesis       Date:  2018-03-13       Impact factor: 7.485

10.  Cytoplasmic Citrate Flux Modulates the Immune Stimulatory NKG2D Ligand MICA in Cancer Cells.

Authors:  Sofie H Møller; Maiken Mellergaard; Mikkel Madsen; Amaia V Bermejo; Stine D Jepsen; Marie H Hansen; Rikke I Høgh; Blanca I Aldana; Claus Desler; Lene Juel Rasmussen; Elahu G Sustarsic; Zachary Gerhart-Hines; Evangelia Daskalaki; Craig E Wheelock; Thomas K Hiron; Da Lin; Christopher A O'Callaghan; Hans H Wandall; Lars Andresen; Søren Skov
Journal:  Front Immunol       Date:  2020-08-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.